FCPM III SERVICES B.V.
CIK 2013410
13F filing for Q2 2026・No. 3,078
- Holdings
- US$750.41M
- Quarter change
- +US$28.2M
- Entries
- 15
- Net bought (estimate)
- −US$12.91M
The quarter change is the holdings' value against the quarter before, price moves included — not what was bought or sold; each institution's page estimates that.
Net bought (estimate)
Each stock's change in shares at the quarter-end price, added up: a new position counts as bought, one sold out as sold, shares held long only. Splits are compared split-adjusted; corporate actions under a new CUSIP are not estimated. An estimate from the filings, not actual trades.
- New 1
- Sold out 0
- Cut 2
- Added 0
- Corporate actions 0
- Unchanged 8
Largest holdings
11 stocks worth US$750.41M, options and bonds left out.
| Stock | This quarter | Shares | Value | Weight |
|---|---|---|---|---|
| NAMSNEWAMSTERDAM PHARMA COMPANYORDINARY SHARES | Cut | 8,490,353 | US$287.74M | 38.34% |
| MAPLIGHT THERAPEUTICS INCCOM | Unchanged | 3,226,400 | US$115.63M | 15.41% |
| DYNE THERAPEUTICS INCCOM | Cut | 3,848,256 | US$85.47M | 11.39% |
| VOR BIOPHARMA INCCOM NEW | Unchanged | 4,117,354 | US$75.8M | 10.10% |
| DAMORA THERAPEUTICS INCCOM NEW | Unchanged | 2,441,000 | US$63.49M | 8.46% |
| REPLIMUNE GROUP INCCOM | Unchanged | 2,808,368 | US$31.09M | 4.14% |
| CRESCENT BIOPHARMA INC.COM | Unchanged | 1,677,852 | US$30.2M | 4.02% |
| AURA BIOSCIENCES INCCOM | New | 4,053,775 | US$28.78M | 3.84% |
| ENGENE HOLDINGS INCCOM | Unchanged | 9,632,561 | US$16.66M | 2.22% |
| BICYCLE THERAPEUTICS PLCSPONSORED ADS | Unchanged | 3,468,430 | US$14.71M | 1.96% |
Sign in (free) to see its 11 largest holdings and its trades. Sign in
Filings
The quarter's original 13F filings (SEC).
- 13F-HRFiled August 14, 2026SEC ↗
13F covers long positions in US-listed securities only; the data is SEC's, filed within 45 days of the quarter's end.